The effects of Vitex agnus-castus supplementation on inflammatory markers in women with PCOS: a randomized, double-blind, placebo-controlled trial

Aniseh Hatami, Hanieh Taheri, Ali Khosrowbeygi, Fateme Seidi, Mohadeseh Azimi, Farideh Jalali-Mashayekhi

Abstract


Background and purpose: To evaluate the effects of Vitex agnus-castus supplementation on serum levels of inflammatory cytokines (primary outcomes:  tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6); secondary outcome: anti-Mullerian hormone (AMH)) in women with polycystic ovary syndrome (PCOS).

Experimental approach: This secondary analysis included 40 serum samples (20 Vitex and 20 placebo) randomly selected from a previously registered randomized, double-blind, placebo-controlled trial in women with PCOS. Participants received either Vitex (5.8 mg/day, standardized to 0.42-0.82 mg aucubin) or a placebo for 12 weeks. Serum TNF-α, IL-6, and AMH were measured at baseline and week 12 using ELISA. Within-group changes were assessed with paired t-tests, and between-group differences were analyzed using independent t-tests and ANCOVA using SPSS v23.0 software.

Findings/Results: Vitex supplementation significantly reduced serum TNF-α (141.27 ± 24.27 to 91.28 ± 19.57 pg/mL), IL-6 (71.72 ± 13.63 to 48.91 ± 24.19 pg/mL), and AMH (11.21 ± 3.89 to 7.88 ± 4.87 ng/mL) levels, whereas the placebo group showed no significant changes. The between-group differences were significant for all markers. These findings suggest potential benefits in reducing inflammation and improving ovarian function, pending confirmation in future clinical outcome studies.

Conclusion and implications: Vitex supplementation may offer a complementary approach to managing inflammation and hormonal disturbances in women with PCOS.

 


Keywords


Anti-Mullerian hormone; Interleukin-6; Polycystic ovary syndrome; TNF-α; Vitex.

Full Text:

PDF

References


Rodriguez-Paris D, Remlinger-Molenda A, Kurzawa R, Głowińska A, Spaczyński R, Rybakowski F, et al. Psychiatric disorders in women with polycystic ovary syndrome. Psychiatr Pol. 2019;53(4):955-966.DOI: 10.12740/PP/OnlineFirst/93105.

Vink JM, Sadrzadeh S, Lambalk CB, Boomsma DI. Heritability of polycystic ovary syndrome in a Dutch twin-family study. J Clin Endocrinol Metab. 2006;91(6):2100-2104.DOI: 10.1210/jc.2005-1494.

Siddiqui S, Mateen S, Ahmad R, Moin S. A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS). J Assist Reprod Genet. 2022;39(11):2439-2473.DOI: 10.1007/s10815-022-02625-7.

Stańczak NA, Grywalska E, Dudzińska E. The latest reports and treatment methods on polycystic ovary syndrome. Ann Med. 2024;56(1):2357737,1-21.DOI: 10.1080/07853890.2024.2357737.

Bednarska S, Siejka A. The pathogenesis and treatment of polycystic ovary syndrome: What’s new? Adv Clin Exp Med. 2017;26(2):359-367.DOI: 10.17219/acem/59380.

Rudnicka E, Suchta K, Grymowicz M, Calik-Ksepka A, Smolarczyk K, Duszewska AM, et al. Chronic low grade inflammation in pathogenesis of PCOS. Int J Mol Sci. 2021;22(7):3789,1-12.DOI: 10.3390/ijms22073789.

Tarkun I, Çetinarslan B, Türemen E, Cantürk Z, Biyikli M. Association between circulating tumor necrosis factor-alpha, interleukin-6, and insulin resistance in normal-weight women with polycystic ovary syndrome. Metab Syndr Relat Disord. 2006;4(2):122-128.DOI: 10.1089/met.2006.4.122.

Li Y, Zheng Q, Sun D, Cui X, Chen S, Bulbul A, et al. Dehydroepiandrosterone stimulates inflammation and impairs ovarian functions of polycystic ovary syndrome. J Cell Physiol. 2019;234(5):7435-7447.DOI: 10.1002/jcp.27501.

Eilertsen TB, Vanky E, Carlsen SM. Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome:can morphologic description be replaced. Hum Reprod. 2012;27(8):2494-2502.DOI: 10.1093/humrep/des213.

Rudnicka E, Kunicki M, Calik-Ksepka A, Suchta K, Duszewska A, Smolarczyk K, et al. Anti-Müllerian hormone in pathogenesis, diagnostic and treatment of PCOS. Int J Mol Sci. 2021;22(22):12264,1-12.DOI: 10.3390/ijms222212507.

Morgante G, Massaro MG, Di Sabatino A, Cappelli V, De Leo V. Therapeutic approach for metabolic disorders and infertility in women with PCOS. Gynecol Endocrinol. 2018;34(1):4-9.DOI: 10.1080/09513590.2017.1370644.

Ortiz-Flores AE, Luque-Ramírez M, Escobar-Morreale HF. Pharmacotherapeutic management of comorbid polycystic ovary syndrome and diabetes. Expert Opin Pharmacother. 2018;19(17):1915-1926.DOI: 10.1080/14656566.2018.1528231.

Samimi F, Baazm M, Eftekhar E, Rajabi S, Goodarzi M, Jalali Mashayekhi F. Possible antioxidant mechanism of coenzyme Q10 in diabetes: impact on Sirt1/Nrf2 signaling pathways. Res Pharm Sci. 2019;14(6):524-533.DOI: 10.4103/1735-5362.272561.

Mafi A, Mokhtari Z, Hosseini E, Alimohammadi M, Aarabi MH, Askari G. Effect of saffron (Crocus sativus) supplementation on oxidative stress, inflammatory indices, and renal and liver function parameters in patients with type 2 diabetes mellitus:a GRADE-assessed systematic review and meta-analysis of randomized clinical trials. Nutr Rev. 2025;83(6):971-987.DOI: 10.1093/nutrit/nuae121.

Roustaei Rad N, Movahedian A, Feizi A, Aminorroaya A, Aarabi M. Antioxidant effects of astaxanthin and metformin combined therapy in type 2 diabetes mellitus patients: a randomized double-blind controlled clinical trial. Res Pharm Sci. 2022;17(2):219-230.DOI: 10.4103/1735-5362.335179.

Li W, Liu C, Yang Q, Zhou Y, Liu M, Shan H. Oxidative stress and antioxidant imbalance in ovulation disorder in patients with polycystic ovary syndrome. Front Nutr. 2022;9:1018674,1-10.DOI: 10.3389/fnut.2022.1018674.

Kavaz A, Işık M, Dikici E, Yüksel M. Anticholinergic, antioxidant, and antibacterial properties of Vitex agnus-castus L. seed extract: assessment of its phenolic content by LC/MS/MS. Chem Biodivers. 2022;19(10):e202200143,1-10.DOI: 10.1002/cbdv.202200143.

Feyzollahi Z, Kouchesfehani HM, Jalali H, Eslimi-Esfahani D, Hosseini AS. Effect of Vitex agnus-castus ethanolic extract on hypothalamic KISS-1 gene expression in a rat model of polycystic ovary syndrome. Avicenna J Phytomedicine. 2021;11(3):292-301.PMID: 34046325.

Shahnazi M, Khalili AF, Hamdi K, Ghahremaninasab P. The effects of combined low-dose oral contraceptives and Vitex agnus on the improvement of clinical and paraclinical parameters of polycystic ovarian syndrome: a triple-blind, randomized, controlled clinical trial. Iran Red Crescent Med J. 2016;18(12):e37987,1-11.DOI:10.5812/ircmj.37510.

Hatami A, Seidi F, Khosrowbeygi A, Moslemi A. The effect of Vitex Agnus - Castus plant on some markers of oxidative stress, lipid profile and insulin resistance in women with polycystic ovary syndrome: a randomized, double-blind controlled clinical trial study. JBRA Assist Reprod. 2025 (Advanced View).DOI: 10.5935/1518-0557.20250165.

Gao L, Gu Y, Yin X. High serum tumor necrosis factor-alpha levels in women with polycystic ovary syndrome: a meta-analysis. PLoS One. 2016;11(10):e0164021,1-18.DOI: 10.1371/journal.pone.0164021.

Oróstica L, Poblete C, Romero C, Vega M. Pro-inflammatory markers negatively regulate IRS1 in endometrial cells and endometrium from women with obesity and PCOS. Reprod Sci. 2020;27(1):290-300.DOI: 10.1007/s43032-019-00026-3.

Oróstica L, García P, Vera C, García V, Romero C, Vega M. Effect of TNF-α on molecules related to the insulin action in endometrial cells exposed to hyperandrogenic and hyperinsulinic conditions, characteristics of polycystic ovary syndrome. Reprod Sci. 2018;25(7):1000-1009.DOI: 10.1177/1933719117732157.

Thathapudi S, Kodati V, Erukkambattu J, Katragadda A, Addepally U, Hasan Q. Tumor necrosis factor-alpha and polycystic ovarian syndrome: a clinical, biochemical, and molecular genetic study. Genet Test Mol Biomarkers. 2014;18(9):605-609.DOI: 10.1089/gtmb.2014.0151.

Yu H, Gao X, Ge Q, Tai W, Hao X, Shao Q, et al. Tumor necrosis factor-α reduces adiponectin production by decreasing transcriptional activity of peroxisome proliferator-activated receptor-γ in calf adipocytes. J Dairy Sci. 2023;106(7):5182-5195.DOI: 10.3168/jds.2022-22919.

Al-Ajwady HAN, Al-Zobidy AMH. Effect of Vitex agnus-castus ethanolic extract and clomiphene citrate on oxidative stress and immunological parameters in female rats with polycystic ovary syndrome induced by letrozole. Reprod Heal East Eur. 2024;14(3):389-395.DOI: 10.34883/PI.2024.14.3.009.

Kariyawasam KWJC, Sirisena PDNN, Nanayakkara HLC, Ratnasooriya WD, Handunnetti SM. Vitex negundo L. leaf extract inhibits IL-6 and TNF-α secretion and phagocytosis in human leukocytes. J Herb Med. 2020;21:100341,1-7.DOI: 10.1016/j.hermed.2020.100341.

Enechukwu CI, Onuegbu AJ, Olisekodiaka MJ, Eleje GU, Ikechebelu JI, Ugboaja JO, et al. Oxidative stress markers and lipid profiles of patients with polycystic ovary syndrome in a Nigerian tertiary hospital. Obstet Gynecol Sci. 2019;62(5):335-343.DOI: 10.5468/ogs.2019.62.5.335.

Hu M, Li F, Wang W. Vitexin protects dopaminergic neurons in MPTP-induced Parkinson’s disease through PI3K/AKT signaling pathway. Drug Des Devel Ther. 2018;12:565-573.DOI: 10.2147/DDDT.S156920.

Yahaya MAF, Zolkiffly SZI, Moklas MAM, Hamid HA, Stanslas J, Zainol M, et al. Possible epigenetic role of vitexin in regulating neuroinflammation in Alzheimer’s disease. J Immunol Res. 2020;2020:9469210,1-7.DOI: 10.1155/2020/9469210.

Li X, Wang Y. Cinnamaldehyde attenuates the progression of rheumatoid arthritis through down-regulation of PI3K/AKT signaling pathway. Inflammation. 2020;43(5):1729-1741.DOI: 10.1007/s10753-020-01246-5

Ahangarpour A, Oroojan AA, Khorsandi L, Najimi SA. Pancreatic protective and hypoglycemic effects of Vitex agnus-castus L. fruit hydroalcoholic extract in D-galactose-induced aging mouse model. Res Pharm Sci. 2017;12(2):137-143.DOI: 10.4103/1735-5362.202452.

Abduljabbar HA, Mahmood MM, Al-Jbooriay MJ, Al-obaidi MT. Concurrent autoimmune and endocrine dysregulation in polycystic ovary syndrome. Middle East Fertil Soc J. 2025;30(1):23,1-10.DOI: 10.1186/s43043-025-00236-7.

Su P, Chen C, Sun Y. Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation. J Ovarian Res. 2025;18(1):34,1-10.DOI: 10.1186/s13048-025-01621-6.

Adams J, Liu Z, Ren YA, Wun WS, Zhou W, Kenigsberg S, et al. Enhanced inflammatory transcriptome in the granulosa cells of women with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2016;101(9):3459-3468.DOI: 10.1210/jc.2015-4275.

Vale-Fernandes E, Carrageta DF, Moreira MV, Guerra-Carvalho B, Rodrigues B, Sousa D, et al. Follicular fluid profiling unveils anti-Müllerian hormone alongside glycolytic and mitochondrial dysfunction as markers of polycystic ovary syndrome. Mol Cell Endocrinol. 2025;602:112536, 1-9.DOI: 10.1016/j.mce.2025.112536.


Refbacks

  • There are currently no refbacks.


Creative Commons LicenseThis work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.